Pubblicazioni

Efficacy and safety of neoadjuvant pertuzumab plus trastuzumab in combination with chemotherapy regimen in Chinese patients with HER2-positive early breast cancer: a real-world retrospective multi-center cohort study

2022 - ANNALS OF TRANSLATIONAL MEDICINE

Zhou, Meirong; Wang, Shouman; Wan, Nengbin; Yuan, Songlin; Hu, Xiongqiang; Zhou, Wei; Qing, Bohua; Liu, Mingwen; Sun, Weihua; Fan, Peizhi; Wang, Jianguo; Cao, Hong; Xu, Haifan; Dai, Bin; Tang, Peizhi; Qian, Liyuan; Zhao, Xi; Xiao, Jun; Zhou, Huaiying; Hu, Jinhui; Ding, Li; Tripodi, Domenico; Zdenkowski, Nicholas; OâKeefe, Thomas J.; Sanchez, Alejandro Martin; Chen, Li; Zhang, Ping; Xu, Feng